Feedback Share Discussion Threads

[petekand] 19/9/2018 14:19

BUT it is not the first time such a situation has arisen on the AIM.
Ignore all the good news and then suddenly from nowhere the price is moving up in pennies! We shall see.

[petekand] 19/9/2018 14:15

That's okay LR. The tech is indeed staggering otherwise we would not see Samsung within a mile of Texrad. And the market attaches no value as the price is below the headline news. Hmmm.




Samsung in Korea takes Cambridge medical imaging technology

10 September 2018


Feedback plc, an AIM-quoted medical imaging technology business anchored in Cambridge UK, has won a significant order to supply the Samsung Medical Centre in Seoul.

The deal is for Feedback's TexRAD patented image texture analysis technology and has been secured through Feedback's South Korean distributor, Korea Computer Motion ISG. The success follows an exclusive distributor arrangement announced on last year granting Korea ISG the ability to sell and distribute TexRAD in South Korea for research purposes, performing advanced analysis of routinely acquired medical diagnostic images, such as CT and MRI scans.

To date, Korea ISG has obtained several orders for the TexRAD software technology in South Korea. This is the first order from Samsung Medical Centre, one of the nation's leading hospital groups, founded by Samsung Group. Samsung Medical Centre has a strong focus on research, particularly in radiology and oncology.

Dr Balaji Ganeshan, global business development director of the AIM company's specialist subsidiary Feedback Medical Ltd, said: "The order of TexRAD by such a cutting-edge medical facility as the Samsung Medical Centre is a great validation of the capabilities of our technology platform.

"We are seeing increasing traction within our international distributor network as our reputation grows."

Feedback has the experienced life science entrepreneur Dr Alastair Riddell as its executive chairman and its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge. Its proprietary technologies are TexRAD, the quantitative texture analysis tool and Cadran, a picture archiving communication system.

[lr2] 19/9/2018 14:10

I won't post on a ydder board. I have standards.

[ducatiman] 19/9/2018 14:06

Needs to be a blue poster Pete. Only 2 blues I have seen are ashtree and ydder!! I am sure we will get a new thread soon enough.

[lr2] 19/9/2018 14:04

"The tech is staggering and the market is currently attaching no value whatsoever."

That makes us clever and the market stupid Pete. Enjoy and bask in the feeling. A bit of exceptional news in the coming days might make the market take notice I suppose. Actually, I'm damn sure it will.

I've no intention of starting up a new thread, I rather like this 'quaint relic' of a thread.

[petekand] 19/9/2018 13:55

A real corporate identity now with the launch of the website today. A future £100 mil plus company in the making. The tech is staggering and the market is currently attaching no value whatsoever.
Anyhow thought the launch of Fdbk Med may have nudged LR to finally setup a thread that actually relates to this company?

[lr2] 19/9/2018 13:42

Now 1.615p (200k) - 1.7p (100k).

[lr2] 19/9/2018 13:14

Current on line limits.

Sell 200k at 1.57p (up to 1.595p for small amounts).
Buy 250k at 1.69p (no discount for small amounts).

[ducatiman] 19/9/2018 11:25

Currently 1.53-1.6

[ducatiman] 19/9/2018 11:18

As LR2 pointed out all of today's trades are buys.

[ducatiman] 19/9/2018 11:16

That was the buy price when the trade was executed at 08:42

[cyberbub] 19/9/2018 11:09

How do we know the 500k is a buy? Doesn't seem logical to me.

[ducatiman] 19/9/2018 09:46

Yep, 500k buy just reported.

[lr2] 19/9/2018 09:44

All buys today... incl the delayed 500k.

[lr2] 19/9/2018 09:40

Yes. Nailed on. Sometime soon.

[ducatiman] 19/9/2018 09:20

Can we now expect an "event"?

[ducatiman] 19/9/2018 08:28

Aha, new website now live!

[lr2] 19/9/2018 08:23

Just me being silly Duc. Try this one instead,

[ducatiman] 19/9/2018 08:19

Link not working for me LR2

[ducatiman] 16/9/2018 11:30

Trading in the first quarter was "exceptional". Recruiting. An "upcoming event". New website to go live "later this month". Siemens "bundling". Negatives:- will there be a placing? Chart looks awful, opposite to where it should be given newsflow and potential.

[lr2] 16/9/2018 10:37

You're welcome Ash. Feedback products are highly regarded and I hope that, by pointing out falsehoods published by one particularly disgruntled ex-employee, the people who read this board get a truer view of the progress being made by the company.

I hope that some very good news is about to be released in the coming weeks and that the share price will finally reflect future prospects. Do keep your eyes open for the coming news as it could be a real turning point for Feedback.

[ashtree2] 16/9/2018 08:30

LR2...thanks for your good work on this board.ash

[ashtree2] 16/9/2018 08:29

Management

The Board of Directors

Trevor Brown

Chief Executive

Trevor has been a strategic investor in equities and real estate for more than 30 years. He is currently a Non-executive Director of Feedback plc and was until recently a director of Advanced Oncotherapy plc where he was involved in the strategy of transition to the provision of advanced cancer treatment services. Trevor joined the Board of Braveheart as a Non-executive Director on 1 April 2014 and was appointed Chief Executive on 24 August 2015.

The above does not seem to be on the Braveheart website.